Page last updated: 2024-09-02

acetylleucyl-leucyl-norleucinal and degrasyn

acetylleucyl-leucyl-norleucinal has been researched along with degrasyn in 2 studies

Compound Research Comparison

Studies
(acetylleucyl-leucyl-norleucinal)
Trials
(acetylleucyl-leucyl-norleucinal)
Recent Studies (post-2010)
(acetylleucyl-leucyl-norleucinal)
Studies
(degrasyn)
Trials
(degrasyn)
Recent Studies (post-2010) (degrasyn)
32105337033

Protein Interaction Comparison

ProteinTaxonomyacetylleucyl-leucyl-norleucinal (IC50)degrasyn (IC50)
Ubiquitin carboxyl-terminal hydrolase isozyme L1Homo sapiens (human)3
Ubiquitin carboxyl-terminal hydrolase 5Homo sapiens (human)3
Probable ubiquitin carboxyl-terminal hydrolase FAF-XHomo sapiens (human)4.625

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abe, N; Akiyama, T; Koshino, H; Okada, K; Onose, J; Takahashi, S; Taniguchi, K; Yajima, A; Yajima, S; Ye, YQ; Yoshida, A; Yoshioka, Y1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

2 other study(ies) available for acetylleucyl-leucyl-norleucinal and degrasyn

ArticleYear
Vialinin A is a ubiquitin-specific peptidase inhibitor.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Endopeptidases; Protease Inhibitors; Protein Binding; Rats; Recombinant Proteins; Terphenyl Compounds

2013
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023